Please provide your email address to receive an email when new articles are posted on . CHICAGO — In this video, Susana M. Campos, MD, MPH, discusses results from a single-arm phase 2 study of the ...
Hosted on MSN
Akeso’s Phase II Study on AK104: A Potential Game-Changer for Vulvar Cancer Treatment
Akeso, Inc. ((HK:9926)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback